|
Category
|
aURTDa
|
FLUTDb
|
Abscesses
|
|---|
|
2016
|
2018
|
2016
|
2018
|
2016
|
2018
|
|---|
|
AMUcindicated
|
n = 64
|
n = 78
|
n = 57
|
n = 55
|
n = 65
|
n = 82
|
|
% [CI]d
|
% [CI]d
|
% [CI]d
|
% [CI]d
|
% [CI]d
|
% [CI]d
|
|
Guidelines followed
|
10.9 [4.5–21.2]
|
16.7 [9.2–26.8]
|
38.6 [26.0–52.4]
|
45.5 [32.0–59.4]
|
50.8 [38.1–63.4]
|
41.5 [30.7–52.9]
|
|
Guidelines not followed
|
|
a. Different dose/duration
|
6.3 [1.7–15.2]
|
2.6 [0.3–9.0]
|
1.8 [0.0–9.4]
|
5.5 [1.1–15.1]
|
24.6 [14.8–36.9]
|
34.1 [24.0–45.4]
|
|
b. Different antimicrobial class
|
75.0 [62.6–85.0]
|
67.9 [56.4–78.1]
|
54.4 [40.7–67.6]
|
38.2 [25.4–52.3]
|
21.5 [12.3–33.5]
|
22.0 [13.6–32.5]
|
|
c. Unjustified non-use
|
7.8 [2.6–17.3]
|
12.8 [6.3–22.3]
|
5.3 [1.1–14.6]
|
10.9 [4.1–22.2]
|
3.1 [0.4–10.7]
|
2.4 [0.3–8.5]
|
|
AMUcnot indicated
|
n = 120
|
n = 92
|
n = 106
|
n = 109
|
n = 66
|
n = 47
|
|
% [CI]d
|
% [CI]d
|
% [CI]d
|
% [CI]d
|
% [CI]d
|
% [CI]d
|
|
Guidelines followed
|
35.0 [26.5–44.2]
|
55.4 [44.7–65.8]
|
55.7 [45.7–65.3]
|
67.9 [58.3–76.5]
|
4.5 [0.9–12.7]
|
19.1 [9.1–33.3]
|
|
Treatment duratione
|
n = 140
|
n = 127
|
n = 178
|
n = 134
|
n = 153
|
n = 164
|
|
% [CI]d
|
% [CI]d
|
% [CI]d
|
% [CI]d
|
% [CI]d
|
% [CI]d
|
|
Guidelines followed
|
89.3 [82.9–93.9]
|
88.2 [81.3–93.2]
|
44.4 [37.0–52.0]
|
54.5 [45.7–63.1]
|
39.2 [31.4–47.4]
|
39.6 [32.1–47.6]
|
|
Guidelines not followed
|
|
a. Too long
|
10.7 [6.1–17.1]
|
10.2 [5.6–16.9]
|
50.6 [43.0–58.1]
|
38.8 [30.5–47.6]
|
57.5 [49.3–65.5]
|
56.1 [48.1–63.8]
|
|
b. Too short
|
0.0 [0.0–2.6]
|
1.6 [0.2–5.6]
|
5.1 [2.3–9.4]
|
6.7 [3.1–12.4]
|
3.3 [1.1–7.5]
|
4.3 [1.7–8.6]
|
- Non-overlapping 95% confidence intervals are shown in bold; Data from cases from 2016 has been published previously [45]; aaURTD, acute upper respiratory tract disease; bFLUTD, feline lower urinary tract disease; cAMU, antimicrobial use; dCI, 95% confidence interval; eTreatment duration is unknown for numbers not listed (2016: n = 111; 2018: n = 103)
